PACS Group, Inc. (PACS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $7.78B
Last updated: Nov 17, 2026 at 4:25 PM ET
PACS Group, Inc. (PACS) Statistics
PACS Group (PACS) has a market cap of $7.78B and an enterprise value of $7.93B. Its return on invested capital of 19.90% compares with a 10.92% median across 10 similar companies.
Total Valuation
Enterprise value is 2.02% above the market cap, as debt exceeds cash.
| Market Cap | $7.78B |
|---|---|
| Enterprise Value | $7.93B |
| Latest price (Nov 17, 2026) | $48.55 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.3x and 6.3x.
| P/E Ratio | 20.8x |
|---|---|
| Forward P/E | 19.1x |
| P/S Ratio | 1.3x |
| Forward P/S | 1.3x |
| P/B Ratio | 6.3x |
| P/TBV Ratio | 7.2x |
| P/FCF Ratio | 932.0x |
| P/OCF Ratio | 13.4x |
| PEG Ratio | 0.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.7x EBITDA and 951.0x free cash flow.
| EV / Earnings | 28.6x |
|---|---|
| EV / Sales | 1.4x |
| EV / EBITDA | 15.7x |
| EV / EBIT | 18.7x |
| EV / FCF | 951.0x |
Price Statistics
The stock is up 358.88% over 52 weeks and trades 6.82% above its 50-day average.
| Beta (1Y) | 0.56 |
|---|---|
| 52-Week Change | +358.88% |
| 1-Month Change | +5.89% |
| 3-Month Change | +9.69% |
| 6-Month Change | +32.22% |
| Total Return (1Y) | +358.88% |
| Return vs SPY (1Y) | +224.89% |
| Max Drawdown (1Y) | -27.89% |
| Max Drawdown (3Y) | -82.04% |
| Sharpe Ratio (1Y) | 1.74 |
| Correlation with SPY (1Y) | 0.11 |
| 50-Day Average | $45.45 |
| 200-Day Average | $40.50 |
| 52-Week Range | $14.09 to $51.68 |
| RSI (14 Days) | 53.7 |
| Average Volume (20 Days) | 876.68K |
Financial Position
Current assets cover 0.80x current liabilities, and total debt is 0.22x shareholder equity.
| Current Ratio | 0.80x |
|---|---|
| Quick Ratio | 0.80x |
| Debt / Equity | 0.22x |
| Debt / EBITDA | 0.54x |
| Debt / FCF | 33.01x |
| Interest Coverage | 16.21x |
Returns and Efficiency
Return on invested capital is 19.90% and return on equity is 22.86% over the last 12 months.
| Return on Equity (ROE) | 22.86% |
|---|---|
| Return on Assets (ROA) | 4.69% |
| Return on Invested Capital (ROIC) | 19.90% |
| Return on Capital Employed (ROCE) | 8.95% |
| Asset Turnover | 0.99x |
| Receivables Turnover | 7.74x |
Taxes
Income tax took 30.19% of pretax income over the last 12 months.
| Income Tax (TTM) | $120.08M |
|---|---|
| Effective Tax Rate | 30.19% |
Scores
PACS has an Altman Z-Score of 2.26, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.26 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $5.71B over the last 12 months is up 11.02% from the 12 months before.
| Revenue | $5.71B |
|---|---|
| Revenue Growth (YoY) | +11.02% |
| Gross Profit | $1.36B |
| Operating Income | $423.77M |
| Pretax Income | $397.70M |
| Net Income | $277.61M |
| EBITDA | $500.65M |
| EBIT | $423.84M |
| Reported EPS (TTM) | $2.33 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 20.44% of the $5.92B in total assets.
| Cash and Equivalents | $115.28M |
|---|---|
| Total Debt | $272.33M |
| Net Debt | $157.05M |
| Net Debt Per Share | $0.99 |
| Working Capital | -$235.56M |
| Shareholder Equity | $1.21B |
| Book Value Per Share | $7.67 |
| Tangible Book Value | $1.06B |
| Tangible Book Per Share | $6.71 |
| Total Assets | $5.92B |
| Total Liabilities | $4.70B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $571.44M of capital spending, operating cash flow left $8.25M of free cash flow.
| Operating Cash Flow | $579.69M |
|---|---|
| Capital Expenditures | $571.44M |
| Free Cash Flow | $8.25M |
| FCF Per Share | $0.05 |
| Depreciation and Amortization | $76.81M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 7.43%, against a 5-year average of 6.43%.
| Gross Margin | 23.84% |
|---|---|
| Operating Margin | 7.43% |
| Pretax Margin | 6.97% |
| Net Margin | 4.87% |
| EBITDA Margin | 8.78% |
| EBIT Margin | 7.43% |
| FCF Margin | 0.14% |
| Gross Margin (5Y Average) | 20.37% |
| Operating Margin (5Y Average) | 6.43% |
| Net Margin (5Y Average) | 3.79% |
Growth
Revenue grew 29.74% a year over 3 years.
| Revenue Growth (3Y CAGR) | +29.74% |
|---|---|
| FCF Growth (3Y CAGR) | +120.93% |
| Operating Income Growth (3Y CAGR) | +10.52% |
| Book Value Per Share Growth (2Y CAGR) | +208.36% |
| Tangible Book Per Share Growth (2Y CAGR) | +424.51% |
Dividends and Yields
PACS does not pay a dividend. Its free cash flow yield is 0.11%.
| Earnings Yield | 4.81% |
|---|---|
| FCF Yield | 0.11% |
Peer Position
Against 12 similar companies, PACS has the 8th highest P/E and the 7th highest P/S.
P/E RatioPeer median 23.6x
P/S RatioPeer median 1.5x
ROICPeer median 10.92%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.98%
| P/E Ratio | 20.8x vs 23.6x median |
|---|---|
| P/S Ratio | 1.3x vs 1.5x median |
| ROIC | 19.90% vs 10.92% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +11.02% vs +5.98% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PACS
What is PACS's market cap?
PACS Group has a market cap of $7.78B. Its enterprise value, which adds debt and subtracts cash, is $7.93B.
What is PACS's P/E ratio?
PACS Group has a trailing P/E ratio of 20.8x and a forward P/E of 19.1x.
How many shares of PACS are outstanding?
PACS Group has 158.37M shares outstanding. The count is up 1.15% from a year earlier.
Does PACS pay a dividend?
No. PACS Group does not pay a dividend.
How much debt does PACS have?
PACS Group has $272.33M of total debt and $115.28M of cash and equivalents, a net debt position of $157.05M.
PACS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors